Bellevue Healthcare (BBH) Competitors

GBX 143.20
+1.60 (+1.13%)
(As of 05/10/2024 ET)

BBH vs. SDP, SYNC, GSCT, ICGT, JFJ, TFIF, MRCH, TMPL, VOF, and NBPE

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Syncona (SYNC), The Global Smaller Companies Trust (GSCT), ICG Enterprise Trust (ICGT), JPMorgan Japanese (JFJ), TwentyFour Income (TFIF), Merchants Trust (MRCH), Temple Bar (TMPL), VinaCapital Vietnam Opp Fund (VOF), and NB Private Equity Partners (NBPE). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Bellevue Healthcare (LON:BBH) and Schroder Investment Trust - Schroder AsiaPacific Fund (LON:SDP) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bellevue Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Schroder Investment Trust - Schroder AsiaPacific Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.2%. Schroder Investment Trust - Schroder AsiaPacific Fund pays an annual dividend of GBX 12 per share and has a dividend yield of 2.3%. Bellevue Healthcare pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Schroder Investment Trust - Schroder AsiaPacific Fund pays out -7,058.8% of its earnings in the form of a dividend.

Bellevue Healthcare's return on equity of 0.00% beat Schroder Investment Trust - Schroder AsiaPacific Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Bellevue HealthcareN/A N/A N/A
Schroder Investment Trust - Schroder AsiaPacific Fund N/A -3.17%-1.73%

Bellevue Healthcare received 8 more outperform votes than Schroder Investment Trust - Schroder AsiaPacific Fund when rated by MarketBeat users. However, 70.55% of users gave Schroder Investment Trust - Schroder AsiaPacific Fund an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

CompanyUnderperformOutperform
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%
Schroder Investment Trust - Schroder AsiaPacific FundOutperform Votes
103
70.55%
Underperform Votes
43
29.45%

40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 58.1% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by company insiders. Comparatively, 0.8% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Schroder Investment Trust - Schroder AsiaPacific Fund had 1 more articles in the media than Bellevue Healthcare. MarketBeat recorded 1 mentions for Schroder Investment Trust - Schroder AsiaPacific Fund and 0 mentions for Bellevue Healthcare. Schroder Investment Trust - Schroder AsiaPacific Fund's average media sentiment score of 1.11 beat Bellevue Healthcare's score of -0.52 indicating that Schroder Investment Trust - Schroder AsiaPacific Fund is being referred to more favorably in the news media.

Bellevue Healthcare has higher revenue and earnings than Schroder Investment Trust - Schroder AsiaPacific Fund. Schroder Investment Trust - Schroder AsiaPacific Fund is trading at a lower price-to-earnings ratio than Bellevue Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue HealthcareN/AN/AN/A£0.16895.00
Schroder Investment Trust - Schroder AsiaPacific Fund-£19.05M-42.44-£30.14M-£0.17-3,076.47

Summary

Bellevue Healthcare beats Schroder Investment Trust - Schroder AsiaPacific Fund on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£782.80M£825.93M£3.15B£1.65B
Dividend Yield4.48%6.24%4.52%8.47%
P/E Ratio895.00950.63447.731,901.40
Price / SalesN/A14,480.082,109.35397,575.59
Price / CashN/A89.4150.2134.11
Price / BookN/A1.301.502.68
Net IncomeN/A£53.56M£339.54M£177.67M
7 Day Performance-2.72%1.02%0.91%1.25%
1 Month Performance-3.63%1.98%7.82%7.84%
1 Year Performance-6.77%5.10%13.74%10.38%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDP
Schroder Investment Trust - Schroder AsiaPacific Fund
0 of 5 stars
GBX 523
+1.2%
N/A+7.4%£808.40M£-19,050,000.00-3,076.47N/ANews Coverage
SYNC
Syncona
2.0983 of 5 stars
GBX 122
+1.3%
GBX 230
+88.5%
-19.8%£800.20M£-144,460,000.00-488.001,208News Coverage
GSCT
The Global Smaller Companies Trust
0 of 5 stars
GBX 164
+1.4%
N/A+17.1%£826.41M£-19,630,000.00-2,733.33N/ANews Coverage
Positive News
ICGT
ICG Enterprise Trust
0 of 5 stars
GBX 1,184
-1.8%
N/A+10.5%£790.44M£71.10M1,767.16N/ADividend Increase
JFJ
JPMorgan Japanese
0 of 5 stars
GBX 528
+0.6%
N/A+11.1%£777.32M£48.43M1,508.57N/A
TFIF
TwentyFour Income
0 of 5 stars
GBX 102.60
+0.2%
N/A+2.6%£767.28MN/A-3,420.00N/ANews Coverage
MRCH
Merchants Trust
0 of 5 stars
GBX 574
+0.9%
N/A+2.8%£851.36M£-19,550,000.00-2,733.33N/APositive News
TMPL
Temple Bar
0 of 5 stars
GBX 266
+1.7%
N/A+17.8%£764.94M£59.70M1,662.50N/ADividend Announcement
News Coverage
High Trading Volume
VOF
VinaCapital Vietnam Opp Fund
0 of 5 stars
GBX 492
+2.3%
N/A+14.1%£754.93M£5.08M-282.76125Positive News
NBPE
NB Private Equity Partners
0 of 5 stars
GBX 1,630
+0.1%
N/A+4.8%£753.71M£7.05M3,543.48N/A

Related Companies and Tools

This page (LON:BBH) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners